134 related articles for article (PubMed ID: 31622987)
1. Configuration of Primary and Recurrent Aggressive Fibromatosis on Contrast-Enhanced MRI with an Evaluation of Potential Risk Factors for Recurrences in MRI Follow-Up.
Sedaghat S; Surov A; Krohn S; Sedaghat M; Reichardt B; Nicolas V
Rofo; 2020 May; 192(5):448-457. PubMed ID: 31622987
[TBL] [Abstract][Full Text] [Related]
2. Long-term diagnostic value of MRI in detecting recurrent aggressive fibromatosis at two multidisciplinary sarcoma centers.
Sedaghat S; Sedaghat M; Krohn S; Jansen O; Freund K; Streitbürger A; Reichardt B
Eur J Radiol; 2021 Jan; 134():109406. PubMed ID: 33254066
[TBL] [Abstract][Full Text] [Related]
3. Appearance of recurrent dermatofibrosarcoma protuberans in postoperative MRI follow-up.
Sedaghat S; Schmitz F; Sedaghat M; Nicolas V
J Plast Reconstr Aesthet Surg; 2020 Nov; 73(11):1960-1965. PubMed ID: 32952057
[TBL] [Abstract][Full Text] [Related]
4. Does the primary soft-tissue sarcoma configuration predict configuration of recurrent tumors on magnetic resonance imaging?
Sedaghat S; Salehi Ravesh M; Sedaghat M; Meschede J; Jansen O; Both M
Acta Radiol; 2022 May; 63(5):642-651. PubMed ID: 33853376
[TBL] [Abstract][Full Text] [Related]
5. Malignant peripheral nerve sheath tumours in magnetic resonance imaging: primary and recurrent tumour appearance, post-treatment changes, and metastases.
Sedaghat S; Schmitz F; Grözinger M; Sedaghat M
Pol J Radiol; 2020; 85():e196-e201. PubMed ID: 32419885
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of MRI for detecting recurrent soft-tissue sarcoma in a long-term analysis at a multidisciplinary sarcoma center.
Sedaghat S; Sedaghat M; Meschede J; Jansen O; Both M
BMC Cancer; 2021 Apr; 21(1):398. PubMed ID: 33849475
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of High-Field Intraoperative MRI in the Detectability of Residual Tumor in Glioma Grade IV Resections.
Heßelmann V; Mager AK; Goetz C; Detsch O; Theisgen HK; Friese M; Schwindt W; Gottschalk J; Kremer P
Rofo; 2017 Jun; 189(6):519-526. PubMed ID: 28591887
[No Abstract] [Full Text] [Related]
8. Post-treatment complications of soft tissue tumours.
Shapeero LG; De Visschere PJ; Verstraete KL; Poffyn B; Forsyth R; Sys G; Uyttendaele D
Eur J Radiol; 2009 Feb; 69(2):209-21. PubMed ID: 19101106
[TBL] [Abstract][Full Text] [Related]
9. Aggressive fibromatosis: MRI features with pathologic correlation.
Lee JC; Thomas JM; Phillips S; Fisher C; Moskovic E
AJR Am J Roentgenol; 2006 Jan; 186(1):247-54. PubMed ID: 16357411
[TBL] [Abstract][Full Text] [Related]
10. Immediate post-operative MRI suggestive of the site and timing of glioblastoma recurrence after gross total resection: a retrospective longitudinal preliminary study.
Smets T; Lawson TM; Grandin C; Jankovski A; Raftopoulos C
Eur Radiol; 2013 Jun; 23(6):1467-77. PubMed ID: 23314599
[TBL] [Abstract][Full Text] [Related]
11. PROMIS Function Scores Are Lower in Patients Who Underwent More Aggressive Local Treatment for Desmoid Tumors.
Newman ET; Lans J; Kim J; Ferrone M; Ready J; Schwab J; Raskin K; Calderon SL
Clin Orthop Relat Res; 2020 Mar; 478(3):563-577. PubMed ID: 31429829
[TBL] [Abstract][Full Text] [Related]
12. Extra‑abdominal recurrent aggressive fibromatosis: A case series and a literature review.
Asaad SK; Abdullah AM; Abdalrahman SA; Fattah FH; Tahir SH; Omer CS; Rashid RJ; Hassan MN; Mohammed SH; Kakamad FH; Abdalla BA
Mol Clin Oncol; 2023 Oct; 19(4):84. PubMed ID: 37808248
[TBL] [Abstract][Full Text] [Related]
13. Plantar fibromatosis: treatment of primary and recurrent lesions and factors associated with recurrence.
Aluisio FV; Mair SD; Hall RL
Foot Ankle Int; 1996 Nov; 17(11):672-8. PubMed ID: 8946181
[TBL] [Abstract][Full Text] [Related]
14. Breast fibromatosis: Imaging and clinical findings.
Liu H; Zeng H; Zhang H; Wang H; Cheng Z; Hu Y; Wu Z
Breast J; 2020 Nov; 26(11):2217-2222. PubMed ID: 32754995
[TBL] [Abstract][Full Text] [Related]
15. Pediatric aggressive fibromatosis: a retrospective analysis of 13 patients and review of literature.
Buitendijk S; van de Ven CP; Dumans TG; den Hollander JC; Nowak PJ; Tissing WJ; Pieters R; van den Heuvel-Eibrink MM
Cancer; 2005 Sep; 104(5):1090-9. PubMed ID: 16015632
[TBL] [Abstract][Full Text] [Related]
16. Configuration of soft-tissue sarcoma on MRI correlates with grade of malignancy.
Sedaghat S; Salehi Ravesh M; Sedaghat M; Both M; Jansen O
Radiol Oncol; 2021 Jan; 55(2):158-163. PubMed ID: 33600679
[TBL] [Abstract][Full Text] [Related]
17. Correlation between tumor growth and hormonal therapy with MR signal characteristics of desmoid-type fibromatosis: A preliminary study.
Gondim Teixeira PA; Chanson A; Verhaeghe JL; Lecocq S; Louis M; Hossu G; Blum A
Diagn Interv Imaging; 2019 Jan; 100(1):47-55. PubMed ID: 30037746
[TBL] [Abstract][Full Text] [Related]
18. Systematic analysis of post-treatment soft-tissue edema and seroma on MRI in 177 sarcoma patients.
Sedaghat S; Schmitz F; Meschede J; Sedaghat M
Surg Oncol; 2020 Dec; 35():218-223. PubMed ID: 32920505
[TBL] [Abstract][Full Text] [Related]
19. External beam radiotherapy for primary and adjuvant management of aggressive fibromatosis.
Zlotecki RA; Scarborough MT; Morris CG; Berrey BH; Lind DS; Enneking WF; Marcus RB
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):177-181. PubMed ID: 12182989
[TBL] [Abstract][Full Text] [Related]
20. Radiation treatment for aggressive fibromatosis: findings from observed patterns of local failure.
Park HC; Pyo HR; Shin KH; Suh CO
Oncology; 2003; 64(4):346-52. PubMed ID: 12759531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
